Anti-platelets in diabetes management

$48.00 plus tax (Refund Policy)

Download / Buy Article:

Abstract:

Abstract

This study aimed to determine the prevalence of anti-platelet use, and the extent to which contraindications to anti-platelet therapy prevent its use, in 726 diabetic patients attending a private clinic. Among those who reported a history of cardiovascular disease (CVD), 87.1% were on anti-platelet therapy. Of those without prior CVD but with at least one CVD risk factor, 59.8% were not on anti-platelet therapy, but only 7.1% of these had a contraindication to anti-platelet therapy. This study showed that high usage of anti-platelet therapy in diabetic patients with prior CVD is achievable, and that contraindications did not explain low use in those without prior CVD.

Keywords: aspirin; cardiovascular disease; complications; diabetes mellitus; prevention and control; type 2

Document Type: Research Article

DOI: http://dx.doi.org/10.1111/j.1445-5994.2010.02232.x

Affiliations: 1: Baker IDI Heart and Diabetes Institute, and 2: Murdoch Children's Research Institute, Melbourne, Victoria, Australia

Publication date: June 1, 2010

Related content

Tools

Favourites

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more